Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer

  1. Palomero, J.
  2. Panisello, C.
  3. Lozano-Rabella, M.
  4. Tirtakasuma, R.
  5. Díaz-Gómez, J.
  6. Grases, D.
  7. Pasamar, H.
  8. Arregui, L.
  9. Dorca Duch, E.
  10. Guerra Fernández, E.
  11. Vivancos, A.
  12. de Andrea, C.E.
  13. Melero, I.
  14. Ponce, J.
  15. Vidal, A.
  16. Piulats, J.M.
  17. Matias-Guiu, X.
  18. Gros, A.
Aldizkaria:
Journal for immunotherapy of cancer

ISSN: 2051-1426

Argitalpen urtea: 2022

Alea: 10

Zenbakia: 12

Mota: Artikulua

DOI: 10.1136/JITC-2022-005443 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus